Skip to content

Comparative study on the application of remazolam, propofol and etomidate in painless abortion

Comparative study on the application of remazolam, propofol and etomidate in painless abortion

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084751
Enrollment
Unknown
Registered
2024-05-23
Start date
2024-05-26
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless abortion

Interventions

Group R:Remazolam IV
Group B:Propofol IV
Group E:Etomidate IV

Sponsors

Lu'an Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1.ASA? ~ ? grade, female, age =18 years old; 2. Meet the relevant diagnostic criteria for pregnancy in the Diagnostic Criteria for Obstetrics and Gynecology Diseases; 3. Early intrauterine pregnancy was indicated by imaging examination, which was consistent with the indication of painless abortion; 4. Patients and their families were informed of the study purpose and signed consent forms.

Exclusion criteria

Exclusion criteria: 1. Patients with mental disorders; 2. Patients with gynecological diseases or ectopic pregnancy; 3. Patients with tumor diseases, neurological diseases, coagulation disorders and immune deficiencies; 4. There were obvious abnormalities of heart, lung, liver and kidney function before operation; 5.1 Take benzodiazepines or opioids every day for a month or intermittently for nearly 3 months; 6. Recent upper respiratory tract infection and moderate to severe apnea syndrome; 7. None of the patients had any history of severe dysmenorrhea, analgesic drug abuse or drug allergy.

Design outcomes

Primary

MeasureTime frame
Stress response;hemodynamics;Emergence agitation;

Secondary

MeasureTime frame
Adverse event;

Countries

China

Contacts

Public ContactRenhu Li

Lu'an Hospital of Anhui Medical University

lirenhu2008@163.com+86 139 6624 1616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026